|Earnings Power Value||0|
|Net Current Asset Value||0|
|Median P/S Value||0|
|Peter Lynch Value||0|
|DCF (FCF Based)||0|
|DCF (Earnings Based)||0|
MON News and Headlines - Monsanto
According to the GuruFocus All-in-One Screener, the following stocks have reported high business predictability ratings and positive total returns over the past six months. At least five gurus are shareholders of these companies.
Moody's Corp. (MCO) offers opinions and reports to investors and institutions. It has a market cap of $33.61 billion. The company has a 3.5 out of five-star business predictability rating.
The stock has risen 19.3% since the beginning of the year and is trading with a price-earnings ratio of 33.11. The price has been as high as $179.84 and as low as $118.33 in the past
During May and June, GuruFocus Forum users discussed mergers and acquisitions in light of the landmark federal court ruling that enabled AT&T Inc. (T) to complete its merger with Time Warner Inc. (TWX).
Telecom company completes merger with Time Warner days after federal approval
AT&T closed its merger with Time Warner two days after U.S. District Court Judge Richard Leon approved the transaction. The Dallas-based telecom company issued 1.437 shares of its common stock and paid $53.75 in cash per Time Warner share, for a total transaction of 1.185 billion AT&T common
Bayer AG (XTER:BAYN)(BAYRY) announced on Thursday that it closed its merger with Monsanto Co. (MON), a company Warren Buffett (Trades, Portfolio) invested in 7.26 million shares during the first quarter.
The German health care and chemical conglomerate acquired the St. Louis-based agriculture company for $66 billion, or $128 per share. JPMorgan Chase & Co. (JPM) assisted Bayer with the transaction for “the largest acquisition in [Bayer’s] history,” according to the press release.
CEOs comment on landmark merger closing
Hugh Grant, outgoing chairman and CEO of Monsanto, said the closing represents a key milestone toward the company’s
DALLAS, June 5, 2018
DALLAS, June 5, 2018 /PRNewswire/ -- Swank Capital, LLC, and Cushing® Asset Management, LP, announce today an upcoming interim rebalancing of The Cushing® Energy Supply Chain Index (the "Index"). Per the Index's methodology guide, the removal of an Index constituent from a Sub-Index without a named direct replacement necessitates the rebalancing of the Index. On June 4, 2018, S&P Dow Jones Indices announced that Index constituent Monsanto Company (NYSE: MON) will be
The stock in Monsanto Co. (MON) closed slightly at $127.83 a share, up 0.24%, following Bayer AG’s (OTCPK:BAYRY) announcement about its plans to complete the $63 billion merger before Friday.
The German global pharmaceutical and life sciences company counts on receiving all the remaining approvals from regulators by tomorrow.
Werner Baumann is the chairman of Bayer's board of management. He commented: “The acquisition of Monsanto is a strategic milestone in strengthening our portfolio of leading businesses in health and nutrition. We will double the size of our agriculture business and create a leading innovation engine in agriculture, positioning
DALLAS, June 4, 2018
DALLAS, June 4, 2018 /PRNewswire/ -- Swank Capital, LLC, and Cushing® Asset Management, LP, announce today an upcoming interim rebalancing of The Cushing® Energy Supply Chain Index (the "Index"). Per the Index's methodology guide, the removal of an Index constituent from a Sub-Index without a named direct replacement necessitates the rebalancing of the Index. On June 4, 2018, S&P Dow Jones Indices announced that Index constituent Monsanto Company (NYSE: MON) will be
NEW YORK, June 4, 2018
NEW YORK, June 4, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 100, S&P 500 and S&P SmallCap 600 effective prior to the open of trading on Thursday, June 7:
- Netflix Inc. (NASD: NFLX) will replace Monsanto Company (NYSE: MON) in the S&P 100, and Twitter Inc. (NYSE: TWTR) will replace Monsanto in the S&P 500. Bayer Aktiengesellschaft is acquiring Monsanto in a deal
The value investor, who also manages Oakmark’s International Small Cap and Global Select funds, picks stocks with the goal of long-term capital appreciation in mind. He invests mostly in foreign mid- and large-cap companies that are trading at a significant discount to his estimate of intrinsic value.
The four companies that met these criteria in the most recent quarter were Bayer AG (XTER:BAYN), Naspers Ltd. (JSE:NPN), Ryanair Holdings PLC (RYAAY) and Cenovus
The U.S. Department of Justice has approved the union between Monsanto Co. (MON) and Bayer (BAYA).
U.S. regulators had feared that consumers and farmers would be harmed by the merger. But the two companies have allayed those concerns, Bloomberg reports. The U.S. antitrust division has imposed conditions regarding asset sales in order to keep open competive channels. In fact, the agreement between Bayer and Monsanto with the U.S. authorities involves the largest sale of assets ever requested in a merger case.
The $62.5 billion deal is just one step from its final conclusion. The companies
Monsanto Company (MON) has been steadily rising since the announcement that its $62.5 billlion merger with Bayer (BAYA) will close soon.
Bayer CEO Werner Baumann said the deal will be completed by mid-June. Monsanto is expected to give a significant contribution to Bayer’s core net profit starting in 2019 and to its adjusted earnings before interest taxes depreciation and amortization’s (EBITDA).
On Monday, Monsanto was trading at over $127 per share, up 0.51%, reaching its 52-week high.
At the annual meeting of Bayer shareholders, Baumann said that “the company expects synergies to deliver annual contributions of
The global agriculture market has been one of the most exciting places to invest in over the past several years. However, all the excitement appears to lean toward the agrochemical and biotechnology segment, which is comprised of companies like Monsanto Co. (MON).
For pure-play farm products producers and manufacturers like Luxembourg-based Adecoagro SA (AGRO), the going has been tough. Shares of Adecoagro have fallen 35% over the last 15 months and 27% over the last 12 months. It is important to note, however, that a large percentage of the stock's plunge occurred this year. The stock has slumped 22% year
Shares of Monsanto (MON) were unexpectedly flat on Tuesday following the news that the U.S. global agrochemical and agricultural biotechnology corporation received clearance from the antitrust of India as part of a merger with Bayer AG.
Now, the $62.5 billion worth merger between Monsanto and Bayer is just a whisper way from its conclusion.
Monsanto is trading at $125.7 per share and the stock is up 7% so far this year.
The stock is trading above the 200, 100 and 50-SMA lines, as illustrated by the chart powered by GuruFocus and it is only $1.07
Agreement Expands Options for North American Farmers, Reinforces Both Companies' Commitment to Drive Agricultural Productivity through Compelling Choices
WILMINGTON, Del., and ST. LOUIS, May 16, 2018
WILMINGTON, Del., and ST. LOUIS, May 16, 2018 /PRNewswire/ -- Corteva Agriscience™ Agriculture Division of DowDuPont (NYSE: DWDP) and Monsanto Company (NYSE: MON) announced today the completion of a licensing agreement for next-generation technology for insect control in corn for the U.S. and Canada that will expand options for
Berkshire Hathaway Inc. (BRK.A)(BRK.B) CEO Warren Buffett (Trades, Portfolio) disclosed on Tuesday that the conglomerate boosted its position in six companies in the first quarter: Apple Inc. (AAPL), Monsanto Inc. (MON), Teva Pharmaceutical Industries Ltd. (TEVA), US Bancorp (USB), Bank of New York Mellon Corp. (BK) and Delta Air Lines Inc. (DAL).
Buffett buys more Apple during the quarter
Berkshire invested in 74,233,671 shares of Apple for an average price of $172.19 per share. The conglomerate dedicated 6.59% of its portfolio to the transaction. Based on GuruFocus estimates, Buffett is gaining approximately 30% on
The stake of Monsanto Co. (MON) was trimmed by 10.53%, impacting the portfolio by -0.87%.
The company with its subsidiary provides agricultural products for farmers. It has a market cap of $55.18 billion and an enterprise value of $60.63 billion.
GuruFocus gives the company a profitability and growth rating of 8 out of 10. Its return on equity (ROE) of 37.90% and return on assets (ROA) of 11.29% are underperforming 85% of companies in the Global Agricultural
NEW YORK, May 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Forestar Group Inc (:FOR), Altria Group, Inc. (:MO), Investors Bancorp, Inc. (ISBC), Brighthouse Financial, Inc. (BHF), Monsanto Company (:MON), and Cleveland-Cliffs Inc. (:CLF), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
Facebook Inc. (FB) CEO Mark Zuckerberg faced hostile questions from lawmakers yesterday during his appearance before a joint session of the Senate Commerce and Judiciary Committees. Although he may have assuaged investor concerns for the moment, questions still remain about how the Cambridge Analytica scandal and subsequent revelations about misuse of customers' private data will affect the long-term financial health of the company.
Despite the cascade of bad news, some analysts and fund managers remain undaunted. In their view, the fundamentals of the company remain strong and the current crisis will abate over time. Indeed, many of the company’s
After months of back-and-forth negotiations between Bayer AG (XTER:BAYN) (BAYRY) and regulators, the Wall Street Journal reported on Monday the company made a deal with the U.S. Justice Department for antitrust approval of its $62.5 billion takeover of Monsanto Co. (MON).
The German drugs and pesticides company agreed to sell additional assets in exchange for approval, which has been a long time coming. Bayer first approached the world’s largest seeds company with a buyout offer in 2016, increasing the price multiple times before Monsanto finally accepted. According to CNBC, the combined company will control more than a
Monsanto Co. (MON) shares surged on a Wall Street Journal report that the U.S. Justice Department approved the pending $66 billion acquisition by Bayer (BAYRY) after the company agreed to sell additional assets to secure government antitrust approval.
General Motors Co. (GM) rose after Morgan Stanley analyst Adam Jonas upgraded the stock to overweight based on optimism for the company’s pickup truck offerings, which could provide almost two-thirds of the automaker’s profits.
Shares of Therapix Biosciences Ltd. (TRPX) gained more than 25% on positive results from its investigator-initiated phase 2a study at Yale University, in which the THX-110 improved the
U.S. markets are set to open in positive territory on Thursday, with the world hoping that the risk of a trade war became lower after negotiations between U.S. and China.
Shares of Monsanto Co. (MON) rose in premarket trading on the heels of the company reporting its financial results for the second quarter. The company posted earnings per share of $3.22 on revenue of $5.02 billion, registering a decline of 1.0% from the prior-year quarter. The company fell short of estimates in revenue by 9 cents and by $320 million in revenue. Further, the gross profit totaled $3.0 billion for